Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sebaceous carcinoma: evidence-based clinical practice guidelines.
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M. Owen JL, et al. Among authors: sobanko jf. Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. Lancet Oncol. 2019. PMID: 31797796 Review.
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus.
Alam M, Lee A, Ibrahimi OA, Kim N, Bordeaux J, Chen K, Dinehart S, Goldberg DJ, Hanke CW, Hruza GJ, Nehal KS, Olbricht SM, Orringer J, Rohrer TE, Scheinfeld NS, Schmults CD, Strasswimmer JM, Taylor JS, Yoo S, Nodzenski M, Poon E, Cartee T; Cutaneous Surgery Consensus Group. Alam M, et al. JAMA Dermatol. 2014 May;150(5):550-8. doi: 10.1001/jamadermatol.2013.9804. JAMA Dermatol. 2014. PMID: 24599088 Review.
Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR, Sobanko JF, Elenitsas R, Newman JG, Goldbach H, Shin TM, Miller CJ. Etzkorn JR, et al. Among authors: sobanko jf. J Am Acad Dermatol. 2015 May;72(5):840-50. doi: 10.1016/j.jaad.2015.01.007. Epub 2015 Mar 13. J Am Acad Dermatol. 2015. PMID: 25774012
Management Considerations in Extraocular Sebaceous Carcinoma.
Chang AY, Miller CJ, Elenitsas R, Newman JG, Sobanko JF. Chang AY, et al. Among authors: sobanko jf. Dermatol Surg. 2016 Jan;42 Suppl 1:S57-65. doi: 10.1097/DSS.0000000000000575. Dermatol Surg. 2016. PMID: 26730975 Review.
Correlation Between Appropriate Use Criteria and the Frequency of Subclinical Spread or Reconstruction With a Flap or Graft for Melanomas Treated With Mohs Surgery With Melanoma Antigen Recognized by T Cells 1 Immunostaining.
Etzkorn JR, Sobanko JF, Shin TM, Elenitsas R, Chu EY, Gelfand JM, Margolis DJ, Newman JG, Goldbach H, Miller CJ. Etzkorn JR, et al. Among authors: sobanko jf. Dermatol Surg. 2016 Apr;42(4):471-6. doi: 10.1097/DSS.0000000000000693. Dermatol Surg. 2016. PMID: 26990255 Free PMC article.
155 results